You are viewing: India AI in Oncology Market analysis
Part of: AI in Oncology Market (Global)

The India AI in Oncology Market was valued at $86.1 Million in 2024 and projected to reach to $463.3 Million by 2029, representing a compound annual growth rate of 32.4%. India's AI in Oncology market is positioned for exceptional growth, driven by rising cancer incidence, government healthcare initiatives, and increasing investment in medical technology infrastructure.

India AI in Oncology Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India AI in Oncology Market Trends and Insights

  • This accelerated growth reflects India's increasing adoption of artificial intelligence technologies in cancer diagnosis, treatment planning, and patient management across both public and private healthcare systems.
  • India's large patient population, rising healthcare digitalization, and growing investment in oncology infrastructure are driving demand for AI-powered diagnostic and therapeutic solutions. The forecast period from 2024 to 2029 marks a transformative phase for India's oncology sector, as AI integration becomes central to improving diagnostic accuracy and treatment outcomes.
  • India is leveraging AI to address cancer care gaps, enhance pathology workflows, and enable precision medicine approaches in resource-constrained settings.
  • The market's robust 32.4% CAGR underscores India's position as a high-growth market within the Asia Pacific region, supported by government healthcare initiatives, increased private sector participation, and rising awareness of AI-driven oncology solutions among healthcare providers and patients..

Key Market Statistics

  • CAGR (2024-2029) 32.4% CAGR
  • Market Size, 2024 ~USD 86.1 Million
  • Forecast, 2029 ~USD 463.3 Million
  • Country India

India AI in Oncology Market Overview

Rapid Market Expansion :

India's AI in Oncology market is growing at 32.4% CAGR, significantly outpacing the global growth rate of 29.4%, driven by increasing cancer prevalence and healthcare digitalization across the country.

Public-Private Healthcare Integration :

Both government-funded institutions and private healthcare providers in India are increasingly adopting AI-powered oncology solutions for improved diagnostic accuracy and treatment outcomes in cancer care.

Substantial Market Valuation Growth :

The Indian market is projected to grow from USD 86.1 million in 2024 to USD 463.3 million by 2029, representing a 438% increase over five years, reflecting strong investor confidence and clinical adoption.

Technology-Driven Cancer Management :

AI applications in India's oncology sector span diagnosis, treatment planning, and patient management, addressing the critical need for efficient cancer care solutions in a resource-constrained healthcare environment.

India AI in Oncology Market Dynamics

  • The convergence of affordable AI solutions, growing physician adoption, and supportive regulatory frameworks creates a favorable environment for market expansion across tier-1, tier-2, and emerging tier-3 cities. The forecast period through 2029 will witness accelerated deployment of AI-powered diagnostic tools, predictive analytics platforms, and personalized treatment planning systems.
  • Strategic partnerships between Indian healthcare providers and global AI vendors, combined with domestic innovation in cost-effective solutions, will further strengthen market penetration and establish India as a key hub for AI-driven oncology innovation in Asia..

Related Ecosystem

Healthcare Analytics

Top Technologies
  • Machine Learning
  • Natural Language Processing (NLP)
  • Blood Pressure Monitors
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
Top Companies
  • Oracle Corporation
  • PHILIPS HEALTHCARE
  • Siemens healthineers
  • Zensar Technologies Limited
  • EPIC SYSTEMS CORPORATION

    Healthcare It

    Top Technologies
    • Computed Tomography (CT)
    • Machine Learning
    • Magnetic Resonance Imaging (MRI)
    • Natural Language Processing (NLP)
    • Predictive Analytics
    Top Companies
    • CERNER CORPORATION
    • PHILIPS HEALTHCARE
    • Oracle Corporation
    • GE HealthCare Technologies Inc.
    • Siemens healthineers

      Key Takeaways

      • India's AI in Oncology market is valued at USD 86.1 million in 2024 and is forecast to grow to USD 463.3 million by 2029 at a 32.4% CAGR.
      • India's large cancer patient population and healthcare digitalization initiatives are primary drivers of AI adoption in oncology across the country.
      • India is increasingly deploying AI solutions for diagnostic imaging, pathology analysis, and treatment planning to address cancer care capacity challenges.
      • India's position as a high-growth market within Asia Pacific is supported by government healthcare programs, private sector investment, and rising provider awareness of AI technologies.

      AI in Oncology Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment DEEP LEARNING (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 29.4% from 2024 to 2029
      Largest Segment SOLID TUMORS (Cancer Type)
      Market Size Base Year (Billions) ~USD 2.45 (2024)
      Revenue Forecast (Billions) ~USD 8.9 (2029)
      Segments Covered Technology, Type, Application, Cancer Type, End User, Player Type, Deployment Model

      India AI in Oncology Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Technology

      • Computer Vision
      • Context-Aware Processing & Computing
      • Image Analysis
      • Machine Learning
      • Natural Language Processing
      • Natural Language Processing (Nlp)

      By Type

      • Adaptive Trial Design & Monitoring
      • AI-Guided Drug Delivery
      • Brain Tumors
      • Breast Cancer
      • Candidate Selection & Validation
      • Chemotherapy
      • Clinical Trial Optimization
      • Colorectal Cancer
      • Combination & Dose Optimization
      • Computed Tomography
      • Computed Tomography (Ct)
      • Deep Learning
      • Digital Pathology & Histopathology
      • Genetic Risk Prediction
      • Hit Identification & Prioritization
      • Hit-To-Lead Identification/Lead Generation
      • Hospitals & Clinics
      • Imaging & Radiology
      • Immunotherapy
      • Intraoperative Guidance & Robotics
      • Intraoperative Guidance And Robotics
      • Laboratories & Diagnostic Centers
      • Lead Optimization
      • Leukemia
      • Liquid Biopsy & Biomarker Detection
      • Long-Term Prediction
      • Lung Cancer
      • Lymphoma
      • Magnetic Resonance Imaging (Mri)
      • Mammography
      • Mental Health & Support Systems
      • Multiple Myeloma
      • Nuclear Imaging
      • Other Healthcare Providers
      • Other Hematologic Malignancies
      • Other Hematological Malignancies
      • Other Imaging Modalities
      • Other Machine Learning Technologies
      • Other Solid Tumors
      • Other Tumors
      • Others Healthcare Providers
      • Patient Education & Empowerment
      • Personalized Treatment Planning
      • Postoperative Analysis & Recovery
      • Precision Medicine & Genomic Analysis
      • Preclinical Testing
      • Predictive Modeling For Human Trials
      • Predictive Modelling For Human Trials
      • Predictive Models For Treatment Response
      • Preoperative Imaging & 3D Modeling
      • Preoperative Imaging And 3D Modeling
      • Prostate Cancer
      • Radiation Therapy
      • Radiomics & Radiogenomics
      • Radiomics And Radiogenomics
      • Recurrence Monitoring
      • Reinforcement Learning
      • Remote Patient Monitoring
      • Specialty Centers
      • Supervised Learning
      • Surgical Planning & Assistance
      • Symptom Management & Virtual Assistance
      • Target Identification & Validation
      • Targeted Therapy
      • Treatment Recommendation Systems
      • Ultrasound
      • Unsupervised Learning
      • X-Ray Imaging

      By Application

      • Data Management & Analytics
      • Diagnosis & Early Detection
      • Drug Development
      • Drug Discovery
      • Other Applications
      • Patient Engagement & Remote Monitoring
      • Post Treatment Surveillance & Survivorship Care
      • Post-Treatment Surveillance & Survivorship Care
      • Treatment Planning & Personalization

      By Cancer Type

      • Hematologic Malignancies
      • Hematological Malignancies
      • Other Cancer Types
      • Other Cancers
      • Others Cancer Types
      • Solid Tumors

      By End User

      • Academic & Research Institutions
      • Government & Regulatory Agencies
      • Healthcare Payers
      • Healthcare Providers
      • Medical Device/ Equipment Companies
      • Medical Device/Equipment Companies
      • Other End Users
      • Pharmaceutical & Biotechnology Companies

      By Player Type

      • Business Process Service Providers
      • Integrated Suite/Platform Providers
      • Niche/Point Solution Providers
      • Technology Providers

      By Deployment Model

      • Cloud-Based Model
      • Hybrid Model
      • On-Premises Model

      INDIA: AI IN ONCOLOGY MARKET, BY END USER, 2022–2030

      Segment202220232024202520262027202820292030CAGR (%)
      ACADEMIC & RESEARCH INSTITUTIONS5.27.19.312.1162127.836.94932
      GOVERNMENT & REGULATORY AGENCIES1.92.53.24.25.479.111.915.630.1
      HEALTHCARE PAYERS1.31.82.43.145.36.99.212.131.4
      HEALTHCARE PROVIDERS22.731.140.95471.595126.6169.2226.733
      MEDICAL DEVICE/EQUIPMENT COMPANIES4.567.710131722.329.238.530.6
      OTHERS0.81.11.41.92.43.145.16.629
      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES11.916.221.227.936.848.764.686114.832.5
      TOTAL48.465.886.1113.1149.1197261.2347.5463.332.4

      Target Audience

      • Healthcare Technology Vendors : AI and software companies need India-specific market data to develop localized oncology solutions, understand adoption barriers, and identify high-potential customer segments across Indian healthcare institutions.
      • Investment & Private Equity Firms : Investors require detailed India market analysis to evaluate portfolio opportunities, assess growth potential, and make informed funding decisions in the high-growth AI oncology sector.
      • Hospital & Healthcare Networks : Indian healthcare providers need market intelligence to benchmark AI adoption rates, evaluate technology investments, and develop digital transformation strategies for oncology departments.
      • Pharmaceutical & Biotech Companies : Pharma organizations require India market insights to align AI-driven drug development and clinical trial strategies with local oncology market trends and regulatory requirements.
      • Government & Policy Makers : Healthcare administrators and policymakers need comprehensive market data to inform digital health initiatives, healthcare infrastructure planning, and AI adoption policies for cancer care in India.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for India's AI in Oncology market with verified CAGR of 32.4%, enabling accurate financial forecasting and investment decision-making for the 2024-2029 period.
      • Competitive Landscape Intelligence : Understand India-specific market dynamics, key players, and adoption patterns across public and private healthcare sectors to identify competitive positioning and partnership opportunities.
      • Regional Growth Opportunity Assessment : Benchmark India's 32.4% CAGR against global 29.4% growth to recognize India as an outperforming market, justifying prioritized resource allocation and market entry strategies.
      • Healthcare Provider Insights : Access India-focused data on AI implementation in cancer diagnosis, treatment planning, and patient management to guide product development and clinical integration strategies.
      • Investment & Expansion Planning : Leverage comprehensive India market forecasts to support business case development, funding proposals, and go-to-market strategies for oncology AI solutions in South Asia's largest healthcare market.

      Frequently asked questions

      What is the current size of India's AI in Oncology market?

      India's AI in Oncology market was valued at USD 86.1 million in 2024 and is expected to grow significantly through 2029.

      What is the projected market size for India's AI in Oncology sector by 2029?

      India's AI in Oncology market is forecast to reach USD 463.3 million by 2029, driven by increasing adoption and healthcare digitalization.

      What is the CAGR for India's AI in Oncology market?

      India's AI in Oncology market is projected to grow at a compound annual growth rate of 32.4% from 2024 to 2029.

      What factors are driving growth in India's AI in Oncology market?

      Key drivers include India's large cancer patient population, healthcare digitalization initiatives, government support, and rising adoption of AI-powered diagnostic and treatment solutions.

      How does India's AI in Oncology market compare to other Asia Pacific countries?

      India represents a high-growth market within Asia Pacific, with a 32.4% CAGR reflecting strong demand for AI solutions in cancer care and significant investment in healthcare infrastructure.

      RESEARCH METHODOLOGY

      The study involved significant activities to estimate the current size of the AI in oncology. Exhaustive secondary research was done to collect information on the AI in oncology market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in oncology market.

      Secondary Research

      This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in oncology solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

      Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in oncology vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in oncology market.

      After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in oncology solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

      In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

      Breakdown of Primary Participants:

      AI in Oncology Market

      Note 1: Others include sales managers, marketing managers, and product managers.

      Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in oncology. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and markets have been identified through extensive secondary research.
      • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
      AI in Oncology Market

      Data Triangulation

      After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      AI I in oncology is the utilization of AI tools such as machine learning, natural language processing, and computer vision, among others to analyze genomic data and large gene mutations that are unique to an individual’s cancer profile. These AI tools are adopted by various end-users including labs, research centers, hospitals, and biotechnology & pharmaceuticals, among others to address the global cancer burden and the need for precision medicine in oncology.

      Further, AI boosts the speed and accuracy of cancer diagnosis and screening. The major developments include:

      • Pathologists can detect malignancy in prostate biopsy photos with the help of FDA-approved AI software.
      • AI quickly analyzes medical pictures, such as mammograms, increasing radiologists' productivity and enhancing risk assessment and detection of breast cancer.
      • Deep learning is used by NCI scientists to automatically detect precancerous cervical lesions as part of their efforts to improve cervical and prostate cancer screening.

      Stakeholders

      • Clinical/Physician Centers
      • AI Providers
      • Clinical Research Organizations
      • Pharmaceutical/Biopharmaceutical Companies
      • Research and Development (R&D) Companies
      • Business Research and Consulting Service Providers
      • Medical Research Laboratories
      • Academic Medical Centers/Universities/Hospitals
      • Government Agencies
      • Regulatory Agencies
      • Clinical Researchers
      • Clinical Research Organizations
      • Accountable Care Organizations
      • Investors and Venture Capitalists

      Report Objectives

      • To define, describe, and forecast the AI in oncology market based on player type, application, cancer type, technology, deployment model, end user, and region
      • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
      • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
      • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
      • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
      • To profile the key players and comprehensively analyze their market sizes and core competencies
      • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally

      Get the Full AI in Oncology Market Report

      Full forecast, segment splits, and company analysis for all AI in Oncology Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status